JP2010501162A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501162A5 JP2010501162A5 JP2009524367A JP2009524367A JP2010501162A5 JP 2010501162 A5 JP2010501162 A5 JP 2010501162A5 JP 2009524367 A JP2009524367 A JP 2009524367A JP 2009524367 A JP2009524367 A JP 2009524367A JP 2010501162 A5 JP2010501162 A5 JP 2010501162A5
- Authority
- JP
- Japan
- Prior art keywords
- imp
- gene
- lung cancer
- detecting
- expression level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims description 66
- 101710150697 Inositol monophosphatase 1 Proteins 0.000 claims description 46
- 101710126181 Insulin-like growth factor 2 mRNA-binding protein 1 Proteins 0.000 claims description 46
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 34
- 201000005202 lung cancer Diseases 0.000 claims description 34
- 208000020816 lung neoplasm Diseases 0.000 claims description 34
- 239000002773 nucleotide Substances 0.000 claims description 26
- 125000003729 nucleotide group Chemical group 0.000 claims description 26
- 102100029083 Minor histocompatibility antigen H13 Human genes 0.000 claims description 23
- 108091081021 Sense strand Proteins 0.000 claims description 21
- 230000000692 anti-sense effect Effects 0.000 claims description 19
- 108091028664 Ribonucleotide Proteins 0.000 claims description 16
- 239000002336 ribonucleotide Substances 0.000 claims description 16
- 125000002652 ribonucleotide group Chemical group 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 13
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 13
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 13
- 239000012472 biological sample Substances 0.000 claims description 12
- 229940124597 therapeutic agent Drugs 0.000 claims description 12
- 210000004027 cell Anatomy 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 230000000295 complement effect Effects 0.000 claims description 8
- 108091033319 polynucleotide Proteins 0.000 claims description 8
- 239000002157 polynucleotide Substances 0.000 claims description 8
- 102000040430 polynucleotide Human genes 0.000 claims description 8
- 108020004459 Small interfering RNA Proteins 0.000 claims description 7
- 108020004999 messenger RNA Proteins 0.000 claims description 7
- 108091034117 Oligonucleotide Proteins 0.000 claims description 6
- 230000004071 biological effect Effects 0.000 claims description 6
- 238000004393 prognosis Methods 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 claims description 5
- 201000011510 cancer Diseases 0.000 claims description 5
- 210000002919 epithelial cell Anatomy 0.000 claims description 4
- 238000009396 hybridization Methods 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 3
- 108020004414 DNA Proteins 0.000 claims description 2
- 238000010837 poor prognosis Methods 0.000 claims description 2
- 239000000523 sample Substances 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 230000007423 decrease Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 description 20
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 239000012634 fragment Substances 0.000 description 8
- 229920001184 polypeptide Polymers 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 101710150707 Inositol monophosphatase 2 Proteins 0.000 description 1
- 101710126176 Insulin-like growth factor 2 mRNA-binding protein 2 Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102100030403 Signal peptide peptidase-like 2A Human genes 0.000 description 1
- 108050005900 Signal peptide peptidase-like 2a Proteins 0.000 description 1
- 102100023501 Signal peptide peptidase-like 3 Human genes 0.000 description 1
- 101710111748 Signal peptide peptidase-like 3 Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83875006P | 2006-08-18 | 2006-08-18 | |
| PCT/JP2007/066324 WO2008020652A1 (en) | 2006-08-18 | 2007-08-16 | Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010501162A JP2010501162A (ja) | 2010-01-21 |
| JP2010501162A5 true JP2010501162A5 (OSRAM) | 2010-10-07 |
Family
ID=38621240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009524367A Pending JP2010501162A (ja) | 2006-08-18 | 2007-08-16 | 肺癌の治療標的及び予後指標としてのｉｍｐ−１癌遺伝子 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20110070245A1 (OSRAM) |
| EP (1) | EP2059610A1 (OSRAM) |
| JP (1) | JP2010501162A (OSRAM) |
| WO (1) | WO2008020652A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11180814B2 (en) * | 2016-05-30 | 2021-11-23 | The Catholic University Of Korea Industry-Academic Cooperation Foundation | Biomarker for diagnosis and prognosis prediction of liver cancer, and use thereof |
| CN111154891B (zh) * | 2020-02-10 | 2023-07-25 | 天津奥群牧业有限公司 | 绵羊igf2bp1基因插入/缺失多态性的检测引物对、试剂盒、方法和应用 |
| WO2025125557A1 (en) * | 2023-12-15 | 2025-06-19 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Composition comprising an antibody which binds to human igf2bp1 present on the cell surface of a target cell |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6255055B1 (en) * | 1998-03-09 | 2001-07-03 | Wisconsin Alumni Research Foundation | c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence |
| US7579160B2 (en) * | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
| US7258860B2 (en) * | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
| ES2360073T3 (es) * | 2004-03-23 | 2011-05-31 | Oncotherapy Science, Inc. | Método para diagnosticar cáncer de pulmón de células no pequeñas. |
| WO2006038212A2 (en) * | 2004-10-04 | 2006-04-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods and compositions for the diagnosis and treatment of cancer |
-
2007
- 2007-08-16 JP JP2009524367A patent/JP2010501162A/ja active Pending
- 2007-08-16 US US12/377,752 patent/US20110070245A1/en not_active Abandoned
- 2007-08-16 WO PCT/JP2007/066324 patent/WO2008020652A1/en not_active Ceased
- 2007-08-16 EP EP07805983A patent/EP2059610A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502115A5 (OSRAM) | ||
| KR102622307B1 (ko) | 후성유전적 염색체 상호작용 | |
| JP6720260B2 (ja) | 癌を患うリスクのある被検体を診断するための方法およびキット | |
| JP2006500949A5 (OSRAM) | ||
| JP2012135301A5 (OSRAM) | ||
| JP2008532477A5 (OSRAM) | ||
| JP2007506426A5 (OSRAM) | ||
| JP2020527047A (ja) | 大腸癌の診断方法 | |
| JP2012501164A5 (OSRAM) | ||
| JP2010535014A5 (OSRAM) | ||
| KR20180082328A (ko) | 전립선 암 예측 방법 | |
| EP2759602A1 (en) | Non-invasive prenatal genetic diagnostic methods | |
| WO2016186987A1 (en) | Biomarker micrornas and method for determining tumor burden | |
| CN108949992B (zh) | 一种与食管鳞癌及其分级相关的生物标志物 | |
| CN108753969B (zh) | 长链非编码rna在肝细胞癌诊疗中的应用 | |
| JP2005537007A5 (OSRAM) | ||
| JP2010501162A5 (OSRAM) | ||
| JP2009505633A5 (OSRAM) | ||
| CN113862369A (zh) | 与肺腺癌对含铂双药化疗敏感性相关的标志物及其应用 | |
| CN110452989B (zh) | 生物标志物在胃癌检测、诊断中的应用 | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| RU2011111387A (ru) | Syngr4 в качестве генов-мишеней для терапии и диагностики рака | |
| CN109609649B (zh) | 一种用于直肠腺癌诊疗的lncRNA | |
| CN113862367A (zh) | 基于miRNA预测肺腺癌患者对含铂双药化疗的敏感性 | |
| KR101988578B1 (ko) | 미병 판별용 마커 |